Hyperpigmentation in a patient with AIDS, receiving rifabutin for disseminated Mycobacterium genavense infection.
Figueras
C
C
Garcia
L
L
Bertran
J M
JM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy*; D009170:Nontuberculous Mycobacteria; D017828:Rifabutin / Q000627:therapeutic use*
D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents; D017828:Rifabutin; D015725:Fluconazole